Evidence map›Paper›PMID 31109134›Full record

ArticleNutrients2019

Ariana Acevedo-Díaz, Gabriela Ortiz-Soto, Ivette J Suárez-Arroyo, Astrid Zayas-Santiago, Michelle M Martínez Montemayor

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Potential Active Compounds ofFood science & nutrition · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Exploring the Therapeutic Potential ofJournal of clinical medicine · 2024
    Review
  6. Anti-Cancer Potential of Edible/Medicinal Mushrooms in Breast Cancer.International journal of molecular sciences · 2023
    Review
  7. Metadherin Regulates Inflammatory Breast Cancer Invasion and Metastasis.International journal of molecular sciences · 2023
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. High-Pressure Supercritical COFrontiers in pharmacology · 2020
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ariana Acevedo-DíazDepartment of Biology, University of Puerto Rico at Bayamón, Bayamón, PR 00959, USA. ari.aceve12@gmail.com.
Gabriela Ortiz-SotoDepartment of Biochemistry, Universidad Central del Caribe-School of Medicine, Bayamón, PR 00960, USA. gabriela.ortiz.soto@gmail.com.
Ivette J Suárez-ArroyoDepartment of Biochemistry, Universidad Central del Caribe-School of Medicine, Bayamón, PR 00960, USA. ivette.suarez@uccaribe.edu.ORCID 0000-0002-5252-9227
Astrid Zayas-SantiagoDepartment of Pathology and Laboratory Medicine, Universidad Central del Caribe-School of Medicine, Bayamón, PR 00960, USA. astrid.zayas@uccaribe.edu.ORCID 0000-0003-4028-0564
Michelle M Martínez MontemayorDepartment of Biochemistry, Universidad Central del Caribe-School of Medicine, Bayamón, PR 00960, USA. michelle.martinez@uccaribe.edu.ORCID 0000-0002-6933-9905
Central University of the Caribbean · PRUniversity of Puerto Rico at Bayamón · PR

Funding

SCIENCE AND TECHNOLOGY COMPETENCY & EDUCATION CORE (STCE)P20GM103475 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI Jose R. Rodriguez-Medina · 2012 to 2026
$52.9M
UNIVERSITY MEDICAL RESEARCH CENTERG12RR003035 · NCRR · UNIVERSIDAD CENTRAL DEL CARIBE · PI RODRIGUEZ, JOSE GINEL · 1986 to 2011
$26.7M
UNIVERSIDAD CENTRAL DEL CARIBE BIOMEDICAL RESEARCH CENTERSG12MD007583 · NIMHD · UNIVERSIDAD CENTRAL DEL CARIBE · PI RODRIGUEZ, JOSE GINEL · 2012 to 2016
$8.4M
Sensitization of breast cancer and cancer stem cell to systemic therapy by ReishiSC3GM111171 · NIGMS · UNIVERSIDAD CENTRAL DEL CARIBE · PI MARTINEZ, MICHELLE M · 2014 to 2019
$461k
National Institute of General Medical Sciences P20GM103475National Institute of General Medical Sciences SC3GM111171National Institute on Minority Health and Health Disparities G12MD007583NCRR NIH HHS G12 RR003035NIGMS NIH HHS P20 GM103475NIGMS NIH HHS SC3 GM111171NIMHD NIH HHS G12 MD007583Puerto Rico Science, Technology and Research Trust 2017-043Puerto Rico Science, Technology and Research Trust Hurricane Relief FundsU.S. Department of Education P031M105050U.S. Department of Education P031S130068
6 · The paper itself

Abstract

Breast cancer (BC) is the second leading cause of cancer death among women worldwide. The main cause of BC morbidity and mortality is the invasiveness capacity of cancer cells that may lead to metastasis. Here, we aimed to investigate the therapeutic efficacy of

Indexed as

ReishiAntineoplastic AgentsBiological ProductsBreast NeoplasmsCarrier ProteinsCell Line, TumorCell MovementCell SurvivalDNA-Binding ProteinsDown-RegulationFemaleHumansMembrane ProteinsNeoplasm InvasivenessProto-Oncogene Proteins c-mycPseudopodiaAntineoplastic AgentsBiological ProductsCarrier ProteinsDNA-Binding ProteinsENA-VASP proteinsMembrane ProteinsMYC protein, humanProto-Oncogene Proteins c-mycrac GTP-Binding ProteinsRAPH1 protein, humanbreast cancercancer cell migrationGanoderma lucidumlamellipodinRac

Identifiers

PMID31109134
PMCPMC6567024
OpenAlexW2946476876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.